Corcept Therapeutics (CORT) Misses Q2 EPS by 4c; Lowers Outlook, $100M Stock Buyback

August 9, 2018 4:25 PM

Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of $0.20, $0.04 worse than the analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found